Dermatopathology 2030: Navigating the Digital, Computational and Molecular Convergence for Precision...

Background: Traditional dermatopathology relies on analog, qualitative pattern recognition, which encounters critical limitations when facing diagnostic "gray zones" and ambiguous tumor proliferations. Objectives: This paper synthesizes a comprehensive framework integrating Whole Slide Imaging (WSI), Artificial Intelligence (AI), and multi-omics to evaluate how this structural convergence redesigns diagnostic risk and safety ecosystems toward 2030. Methods: We analyze the conceptual shift from individual microscope-based observation to multiple data integration. We integrate recent algorithmic computational breakthroughs-including virtual histological staining, deep learning margin mapping, and multimodal report generation-and benchmark human inter-observer discordance. These dimensions are contextualized through an index adult case study from the University Hospital of Geneva. Results: Clinical digitization converts qualitative tissue images into quantitative datasets, potentially reducing some sources of individual cognitive error while introducing new systemic vulnerabilities. The clinical necessity of multi-omics is driven by the limitations inherent in human interpretation of morphology. In our index clinical case of a 45-year-old male with a right arm lesion mimicking a seborrheic keratosis, standard morphology and a wide immunohistochemical panel established a diagnosis of melanoma. High-throughput next-generation sequencing (NGS) provided the molecular evidence to refine the biological classification of the tumor through identification of an oncogenic OPTN::RET fusion, supporting a diagnosis of Spitz melanoma according to the 5th edition of the WHO classification. Layering bulk Gene Expression Profiling (GEP) provides an emerging adjunctive prognostic tool to stratify 5-year recurrence risk and manage clinical crossroads regarding Sentinel Lymph Node Biopsy (SLNB) concordance. Conclusions: There is little doubt that AI will improve histopathological workflows, but its potential weaknesses make human supervision mandatory. By the next decade, dermatopathologists must evolve into multimodal biological experts, responsible for integrating morphology, molecular biology, clinical information, and artificial intelligence. Technology may scale information across global networks, but diagnostic safety should continue to depend on human judgment, contextual interpretation, and the ability to navigate uncertainty.